Common Contracts

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT (INDICATED BY ASTERISKS) HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT SERVICES AGREEMENT

Services Agreement • July 12th, 2013 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • Delaware

• Contract Type
  Services Agreement
• Filed
  July 12th, 2013
• Company
  Sorrento Therapeutics, Inc.
• Industry
  Services-commercial physical & biological research
• Jurisdiction
  Delaware

This Services Agreement (the “Agreement”) is entered into as of March 7, 2013 (the “Effective Date”) by and between SORRENTO THERAPEUTICS, INC., a Delaware corporation (“STI”) having an office at 6042 Cornerstone Court West, Suite B, San Diego, California 92121 (“STI”) and IGDRASOL, INC., a Delaware corporation (“IgDraSol”) having an office at 11100 Warner Avenue, Suite 266, Fountain Valley, California 92708. STI and IgDraSol may be referred to herein individually as a “Party” and collectively as the “Parties.”

SERVICES AGREEMENT

Services Agreement • May 15th, 2013 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • Delaware

• Contract Type
  Services Agreement
• Filed
  May 15th, 2013
• Company
  Sorrento Therapeutics, Inc.
• Industry
  Services-commercial physical & biological research
• Jurisdiction
  Delaware

This Services Agreement (the “Agreement”) is entered into as of March 7, 2013 (the “Effective Date”) by and between SORRENTO THERAPEUTICS, INC., a Delaware corporation (“STI”) having an office at 6042 Cornerstone Court West, Suite B, San Diego, California 92121 (“STI”) and IGDRASOL, INC., a Delaware corporation (“IgDraSol”) having an office at 11100 Warner Avenue, Suite 266, Fountain Valley, California 92708. STI and IgDraSol may be referred to herein individually as a “Party” and collectively as the “Parties.”